MCID: LPT002
MIFTS: 49

Lipoatrophic Diabetes malady

Genetic diseases (common) category
Download this MalaCard

Summaries for Lipoatrophic Diabetes

About this section
Sources:
8Disease Ontology, 65Wikipedia, 33MalaCards
See all sources

Fully expand this MalaCard
Wikipedia:65 Lipoatrophic diabetes is a type of diabetes mellitus presenting with severe lipodystrophy in addition to... more...

MalaCards: Lipoatrophic Diabetes, also known as familial partial lipodystrophy, type 2, is related to diabetes mellitus and lipodystrophy. An important gene associated with Lipoatrophic Diabetes is RETN (resistin), and among its related pathways are Development Leptin signaling via PI3K dependent pathway and SHC1 events in ERBB2 signaling. The compounds actos and saquinavir have been mentioned in the context of this disorder. Affiliated tissues include liver, b cells and adipocyte, and related mouse phenotypes are renal/urinary system and muscle.

Disease Ontology:8 A type 2 diabetes that involves severe lipodystrophy in addition to the traditional signs of diabetes.

Aliases & Classifications for Lipoatrophic Diabetes

About this section
Sources:
8Disease Ontology, 62UMLS, 35MeSH, 58SNOMED-CT, 40NCIt
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Genetic diseases (common)


Aliases & Descriptions:

lipoatrophic diabetes 8
familial partial lipodystrophy, type 2 62


External Ids:

Disease Ontology8 DOID:11712
NCIt40 C34537

Related Diseases for Lipoatrophic Diabetes

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases related to Lipoatrophic Diabetes via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 76)
idRelated DiseaseScoreTop Affiliating Genes
1diabetes mellitus30.7PPARG, INS, LEP, IRS1, ADIPOQ, RETN
2lipodystrophy30.6PPARG, INS, LEP, ADIPOQ, RETN
3insulin resistance30.5PPARG, INS, LEP, IRS1, ADIPOQ, RETN
4congenital generalized lipodystrophy type 230.3PPARG, INS, LEP, ADIPOQ
5acquired generalized lipodystrophy30.2RETN, ADIPOQ, LEP
6hyperglycemia30.1PPARG, INS, LEP, IRS1, ADIPOQ, RETN
7hypertriglyceridemia30.0ADIPOQ, IRS1, LEP, INS, PPARG
8aredyld10.4
9congenital generalized lipodystrophy10.3
10lipodystrophy, familial partial, type 210.3
11rickets10.1
12hepatitis10.1
13liver disease10.1
14neuropathy10.1
15pancreatitis10.1
16retinal degeneration10.1
17retinitis10.1
18ectodermal dysplasia10.1
19nonalcoholic steatohepatitis10.1
20rabson-mendenhall syndrome10.1INS
21bulimia nervosa10.0RETN, LEP
22galactosemia10.0LEP, INS
23eating disorder10.0RETN, LEP
24morbid obesity10.0INS, LEP
25fetal macrosomia10.0INS, LEP
26anovulation10.0LEP, INS
27amenorrhea10.0LEP, INS
28hypopituitarism10.0LEP, INS
29obstructive sleep apnea10.0ADIPOQ, LEP
30pituitary adenoma10.0LEP, PPARG
31hyperthyroidism10.0INS, LEP, RETN
32choriocarcinoma10.0PPARG, LEP, IRS1
33hypothyroidism10.0RETN, LEP, INS
34polycystic ovary syndrome10.0IRS1, LEP, INS
35arteriosclerosis10.0ADIPOQ, PPARG
36infertility10.0INS, LEP, RETN
37type 1 diabetes mellitus10.0RETN, LEP, INS
38familial partial lipodystrophy10.0PPARG, INS, LEP
39primary hyperoxaluria10.0LEP, INS
40familial combined hyperlipidemia10.0INS, ADIPOQ
41bronchitis10.0ADIPOQ, LEP
42anorexia nervosa10.0LEP, ADIPOQ, RETN
43uremia10.0LEP, ADIPOQ, RETN
44cushing's syndrome10.0LEP, ADIPOQ, RETN
45liver cirrhosis10.0RETN, ADIPOQ, IRS1
46pre-eclampsia10.0LEP, ADIPOQ, RETN
47short stature10.0LEP, INS
48hypercholesterolemia10.0RETN, ADIPOQ, INS
49pancreatic cancer10.0PPARG, INS, IRS1
50prediabetes syndrome10.0ADIPOQ, INS, PPARG

Graphical network of the top 20 diseases related to Lipoatrophic Diabetes:



Diseases related to lipoatrophic diabetes

Symptoms for Lipoatrophic Diabetes

About this section

Drugs & Therapeutics for Lipoatrophic Diabetes

About this section
Sources:
42NIH Clinical Center, 6ClinicalTrials
See all sources

Drug clinical trials:

Search ClinicalTrials for Lipoatrophic Diabetes

Search NIH Clinical Center for Lipoatrophic Diabetes

Genetic Tests for Lipoatrophic Diabetes

About this section

Anatomical Context for Lipoatrophic Diabetes

About this section
Sources:
33MalaCards
See all sources

MalaCards organs/tissues related to Lipoatrophic Diabetes:

33
Liver, B cells, Adipocyte

Animal Models for Lipoatrophic Diabetes or affiliated genes

About this section
Sources:
37MGI
See all sources

Publications for Lipoatrophic Diabetes

About this section
Sources:
52PubMed
See all sources

Articles related to Lipoatrophic Diabetes:

(show top 50)    (show all 80)
idTitleAuthorsYear
1
Lipoatrophic diabetes in an elderly woman: clinical course and serum adipocytokine concentrations. (15256772)
2004
2
Long-term leptin-replacement therapy for lipoatrophic diabetes. (15295061)
2004
3
Lipoatrophic diabetes-associated utero-ovarian dysfunction: influence of cellular lipid deposition on norepinephrine indices. (12218377)
2002
4
Lipoatrophic diabetes in Irs1(-/-)/Irs3(-/-) double knockout mice. (12502742)
2002
5
A case of congenital generalized lipodystrophy with lipoatrophic diabetes developing anti-insulin antibodies. (12207821)
2002
6
Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation. (11349722)
2001
7
A-ZIP/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes. (11126232)
2000
8
Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro insulin analog. (10480788)
1999
9
Transgenic mice lacking white fat: models for understanding human lipoatrophic diabetes. (10842669)
1999
10
Human peroxisome proliferator-activated receptor-gamma2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes. (9519760)
1998
11
Dysregulation of insulin-like growth factors in a case of generalized acquired lipoatrophic diabetes mellitus (Lawrence Syndrome) connected with autoantibodies against adipocyte membranes. (9516065)
1998
12
Improved glucose tolerance after effective lipid-lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus: a putative role for Randle's cycle in its pathogenesis? (9156048)
1997
13
Insulin receptor substrate-1 gene variants in lipoatrophic diabetes mellitus and non-insulin-dependent diabetes mellitus: a study of South African black and white subjects. (9385382)
1997
14
No coding mutations are detected in the peroxisome proliferator- activated receptor-gamma gene in Japanese patients with lipoatrophic diabetes. (9356045)
1997
15
Molecular scanning of beta-3-adrenergic receptor gene in total congenital lipoatrophic diabetes mellitus. (9329375)
1997
16
Syndrome of lipoatrophic diabetes, vitamin D resistant rickets, and persistent MA1llerian ducts in a Turkish boy born to consanguineous parents. (8862631)
1996
17
Rheumatological manifestations of lipoatrophic diabetes. (7789070)
1995
18
Lipoatrophic diabetes. (8471812)
1993
19
Lipoatrophic diabetes. (1607489)
1992
20
Successful pregnancy outcome in association with lipoatrophic diabetes mellitus. (2216271)
1990
21
In vitro studies of insulin resistance in patients with lipoatrophic diabetes. Evidence for heterogeneous postbinding defects. (3288531)
1988
22
Metabolic studies in lipoatrophic diabetes: mechanism of hyperglycemia and evidence of resistance to insulin of lipid metabolism. (3292304)
1988
23
Lipid metabolism in lipoatrophic diabetes. (3198064)
1988
24
Case report 417: Lipoatrophic diabetes mellitus (generalized lipodystrophy). (3616671)
1987
25
Physiopathological mechanisms in lipoatrophic diabetes. (3545934)
1986
26
Recurrent ketoacidosis in acquired, total lipodystrophy (lipoatrophic diabetes). (6432502)
1984
27
Altered glucose transport conferring post-receptor insulin resistance to a patient with lipoatrophic diabetes. (6397368)
1984
28
AREDYLD: a syndrome combining an acrorenal field defect, ectodermal dysplasia, lipoatrophic diabetes, and other manifestations. (6638067)
1983
29
Lipoatrophic diabetes: endocrine dysfunction and the response to control hypertriglyceridemia. (6281608)
1982
30
Pancreatic B-cell function and abnormal urinary peptides in a boy with lipoatrophic diabetes and stenosis of the aqueduct of Sylvius. (7004059)
1980
31
The effect of diet upon carbohydrate metabolism, insulin resistance, and blood pressure in congenital total lipoatrophic diabetes. (7005617)
1980
32
Lipoatrophic diabetes with aortic insufficiency. (702234)
1978
33
Renal transplantation in a patient with lipoatrophic diabetes. A case report. (360516)
1978
34
Normal insulin binding to cultured fibroblasts from patients with lipoatrophic diabetes. (849993)
1977
35
Metabolic and endocrine studies in a case of lipoatrophic diabetes. (870793)
1977
36
Binding of insulin to fibroblasts in lipoatrophic diabetes. (882713)
1977
37
Nerve-growth factor and lipoatrophic diabetes. (802991)
1975
38
Familial lipoatrophic diabetes with dominant transmission. A new syndrome. (4362786)
1974
39
Hypothesis: hypothalamic dysfunction and lipoatrophic diabetes. (4365697)
1973
40
Studies on the pathogenesis of lipoatrophic diabetes: a case of congenital systemic absence of adipose tissue associated with insulin-resistant diabetes mellitus and hepatosplenomegaly. (4641790)
1972
41
Lipoatrophic diabetes: a new variant characterized by tapeto-retinal degeneration, late onset generalized lipoatrophy, insulin-resistant hyperglycemia and hyperlipidemia. (5051798)
1972
42
Albright's syndrome and lipoatrophic diabetes. (4115603)
1972
43
Lack of ketosis in lipoatrophic diabetes. (5039834)
1972
44
Serum insulin and growth hormone in lipoatrophic diabetes. (4891081)
1969
45
A diabetogenic polypeptide from hog and sheep adenohypophysis similar to that found in lipoatrophic diabetes. (5651597)
1968
46
LIPOATROPHIC DIABETES. I. STUDIES CONCERNING ENDOCRINE FUNCTION AND CARBOHYDRATE METABOLISM. (14261005)
1965
47
Two sibling cases with lipoatrophic diabetes. (5898664)
1965
48
Lipoatrophic diabetes. (13887740)
1962
49
Generalized lipoatrophy, hepatic cirrhosis, disturbed carbohydrate metabolism and accelerated growth (lipoatrophic diabetes). Longitudinal observations and metabolic studies. (14444009)
1960
50
Lipoatrophic diabetes. (13021561)
1952

Variations for Lipoatrophic Diabetes

About this section
Sources:
1 National Center for Biotechnology Information (Clinvar)
See all sources

Clinvar genetic disease variations for Lipoatrophic Diabetes:

1 (show all 11)
id Gene Name Type Significance SNP ID Assembly Location
1LMNANM_005572.3(LMNA): c.178C> G (p.Arg60Gly)single nucleotide variantPathogenicrs28928900GRCh37Chr 1, 156084887: 156084887
2LMNANM_005572.3(LMNA): c.1580G> C (p.Arg527Pro)single nucleotide variantPathogenicrs57520892GRCh37Chr 1, 156106995: 156106995
3LMNANM_005572.3(LMNA): c.1445G> A (p.Arg482Gln)single nucleotide variantPathogenicrs11575937GRCh37Chr 1, 156106776: 156106776
4LMNANM_005572.3(LMNA): c.398G> T (p.Arg133Leu)single nucleotide variantPathogenicrs60864230GRCh37Chr 1, 156100449: 156100449
5LMNANM_005572.3(LMNA): c.1444C> T (p.Arg482Trp)single nucleotide variantPathogenicrs57920071GRCh37Chr 1, 156106775: 156106775
6LMNANM_005572.3(LMNA): c.1445G> T (p.Arg482Leu)single nucleotide variantPathogenicrs11575937GRCh37Chr 1, 156106776: 156106776
7LMNANM_005572.3(LMNA): c.1394G> A (p.Gly465Asp)single nucleotide variantPathogenicrs61282106GRCh37Chr 1, 156106725: 156106725
8LMNANM_170707.3(LMNA): c.1745G> A (p.Arg582His)single nucleotide variantPathogenicrs57830985GRCh37Chr 1, 156108325: 156108325
9LMNANM_170707.3(LMNA): c.1718C> T (p.Ser573Leu)single nucleotide variantPathogenic, Uncertain significancers60890628GRCh37Chr 1, 156108298: 156108298
10LMNANM_005572.3(LMNA): c.688G> A (p.Asp230Asn)single nucleotide variantPathogenicrs61214927GRCh37Chr 1, 156104644: 156104644
11LMNANM_005572.3(LMNA): c.1195C> T (p.Arg399Cys)single nucleotide variantPathogenicrs58672172GRCh37Chr 1, 156106042: 156106042

Expression for genes affiliated with Lipoatrophic Diabetes

About this section
Sources:
2BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Lipoatrophic Diabetes

Search GEO for disease gene expression data for Lipoatrophic Diabetes.

Pathways for genes affiliated with Lipoatrophic Diabetes

About this section
Sources:
50PathCards, 60Thomson Reuters, 55Reactome, 38NCBI BioSystems Database, 61Tocris Bioscience, 30KEGG, 12EMD Millipore, 53QIAGEN, 51PharmGKB, 5Cell Signaling Technology, 54R&D Systems
See all sources

Pathways related to Lipoatrophic Diabetes according to GeneCards/GeneDecks:

(show all 25)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.5IRS1, LEP
2
Show member pathways
9.5LEP, IRS1
3
Show member pathways
MAPK Cascade38
Immune response Oncostatin M signaling via MAPK in human cells60
Oncostatin M Signaling Pathway38
9.5IRS1, PPARG
4
Show member pathways
Insulin Pathway38
9.4INS, IRS1
59.4IRS1, INS
69.4IRS1, INS
7
Show member pathways
9.3LEP, INS
89.3LEP, INS
9
Show member pathways
9.3INS, PPARG
109.2RETN, ADIPOQ
119.2RETN, ADIPOQ
129.1LEP, ADIPOQ
13
Show member pathways
fatty acid beta-oxidation VI (peroxisome)38
9.1ADIPOQ, PPARG
148.9IRS1, LEP, INS
15
Show member pathways
Prolactin Signaling Pathway38
Development Prolactin receptor signaling60
Leptin signaling pathway38
8.9IRS1, LEP, INS
16
Show member pathways
8.9INS, LEP, IRS1
17
Show member pathways
Transcription Receptor mediated HIF regulation60
Development CNTF receptor signaling60
Class IB PI3K non-lipid kinase events38
ErbB2/ErbB3 signaling events38
Development Growth hormone signaling via PI3K AKT and MAPK cascades60
Translation Regulation activity of EIF260
Regulation of lipid metabolism Insulin signaling generic cascades60
Transcription PPAR Pathway60
Cell adhesion PLAU signaling60
Translation Regulation activity of EIF4F60
8.9PPARG, INS, IRS1
188.7LEP, IRS1, ADIPOQ
19
Show member pathways
8.6ADIPOQ, LEP, PPARG
20
Show member pathways
8.6ADIPOQ, IRS1, INS
218.1PPARG, INS, IRS1, ADIPOQ
22
Show member pathways
8.0ADIPOQ, LEP, INS, PPARG
23
Show member pathways
IL-9 Signaling Pathway38
Development Thrombopoietin regulated cell processes60
IL-7 Signaling Pathway38
Immune response IL 9 signaling pathway60
7.6INS, LEP, IRS1, ADIPOQ, RETN
24
Show member pathways
7.5ADIPOQ, IRS1, LEP, INS, PPARG
257.1RETN, ADIPOQ, IRS1, LEP, INS, PPARG

Compounds for genes affiliated with Lipoatrophic Diabetes

About this section
Sources:
45Novoseek, 11DrugBank, 29IUPHAR, 51PharmGKB, 24HMDB, 61Tocris Bioscience
See all sources

Compounds related to Lipoatrophic Diabetes according to GeneCards/GeneDecks:

(show top 50)    (show all 119)
idCompoundScoreTop Affiliating Genes
1actos459.5INS, PPARG
2saquinavir45 1110.0PPARG, IRS1, ADIPOQ
3stavudine45 1110.0PPARG, ADIPOQ, LEP
411beta-hydroxysteroid458.9LEP, RETN, ADIPOQ
5sulfonylurea458.9ADIPOQ, IRS1, INS
6sibutramine45 119.9INS, LEP, ADIPOQ
7acipimox45 299.8INS, ADIPOQ, LEP
8niacin45 119.7PPARG, ADIPOQ, INS
9bezafibrate45 29 1110.7PPARG, INS, ADIPOQ
10dehydroepiandrosterone sulfate458.6INS, ADIPOQ, LEP
11sterol458.6PPARG, ADIPOQ, IRS1, RETN
12streptozotocin458.6IRS1, INS, ADIPOQ
13nash458.5LEP, RETN, ADIPOQ, INS
14glimepiride45 51 1110.5PPARG, ADIPOQ, RETN, INS
15losartan45 51 29 1111.5PPARG, LEP, ADIPOQ, IRS1
16glycerol 3-phosphate45 249.5LEP, PPARG, ADIPOQ
178-isoprostane458.5INS, RETN, ADIPOQ, LEP
18dhea458.5INS, LEP, RETN, ADIPOQ
19uric acid45 249.5LEP, ADIPOQ, RETN, INS
20ritonavir45 51 1110.4PPARG, ADIPOQ, IRS1, INS
212-deoxyglucose45 119.4INS, PPARG, IRS1, ADIPOQ
22telmisartan45 29 1110.4INS, LEP, ADIPOQ, PPARG
23orlistat45 61 1110.4ADIPOQ, LEP, PPARG, INS
24aicar45 24 1110.4PPARG, LEP, ADIPOQ, INS
25palmitate458.4PPARG, INS, IRS1, ADIPOQ
26fibrinogen458.2RETN, ADIPOQ, LEP, INS
27norepinephrine45 24 1110.2RETN, ADIPOQ, LEP, INS
28glycogen45 249.2INS, ADIPOQ, RETN, IRS1
29c-peptide458.1ADIPOQ, IRS1, LEP, INS, RETN
30fenofibrate45 51 1110.0RETN, ADIPOQ, LEP, INS, PPARG
31thyroxine45 249.0PPARG, INS, RETN, LEP, ADIPOQ
32troglitazone45 29 61 1111.0IRS1, ADIPOQ, LEP, INS, PPARG
33glycerol45 24 119.9LEP, IRS1, INS, PPARG, ADIPOQ
34phosphatidylinositol457.9IRS1, RETN, INS, ADIPOQ, LEP
35rapamycin457.9IRS1, LEP, PPARG, INS, ADIPOQ
36glutamate457.9INS, LEP, IRS1, ADIPOQ, RETN
37alanine457.9PPARG, INS, IRS1, ADIPOQ, RETN
38cholesterol45 29 24 1110.9RETN, ADIPOQ, LEP, INS, PPARG
39wortmannin457.8ADIPOQ, INS, LEP, IRS1
40thiazolidinedione457.6INS, LEP, IRS1, ADIPOQ, RETN, PPARG
41pioglitazone29 45 51 1110.6LEP, ADIPOQ, IRS1, INS, PPARG, RETN
42metformin45 51 119.6PPARG, INS, LEP, RETN, ADIPOQ, IRS1
43rosiglitazone29 45 51 24 1111.6RETN, ADIPOQ, LEP, INS, PPARG, IRS1
44ly294002457.6ADIPOQ, LEP, INS, PPARG, IRS1, RETN
45fatty acid457.6LEP, INS, IRS1, RETN, ADIPOQ, PPARG
46testosterone45 61 24 1110.5RETN, ADIPOQ, IRS1, LEP, INS, PPARG
47dexamethasone45 51 29 1110.5RETN, INS, PPARG, ADIPOQ, LEP, IRS1
48estrogen457.5INS, LEP, IRS1, ADIPOQ, RETN, PPARG
49glucose457.5LEP, ADIPOQ, IRS1, INS, PPARG, RETN
50lipid457.5ADIPOQ, INS, LEP, PPARG, RETN, IRS1

GO Terms for genes affiliated with Lipoatrophic Diabetes

About this section
Sources:
16Gene Ontology
See all sources

Cellular components related to Lipoatrophic Diabetes according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:0056158.1RETN, ADIPOQ, LEP, INS

Biological processes related to Lipoatrophic Diabetes according to GeneCards/GeneDecks:

(show all 24)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of feeding behaviorGO:20002529.8INS, RETN
2positive regulation of glycogen biosynthetic processGO:0457259.7IRS1, INS
3negative regulation of acute inflammatory responseGO:0026749.6PPARG, INS
4placenta developmentGO:0018909.6LEP, PPARG
5regulation of blood pressureGO:0082179.5LEP, PPARG
6response to insulinGO:0328689.4RETN, IRS1, LEP
7fatty acid oxidationGO:0193959.4PPARG, ADIPOQ
8negative regulation of macrophage derived foam cell differentiationGO:0107459.4PPARG, ADIPOQ
9positive regulation of MAPK cascadeGO:0434109.4LEP, INS
10negative regulation of smooth muscle cell proliferationGO:0486629.4ADIPOQ, PPARG
11brown fat cell differentiationGO:0508739.4PPARG, ADIPOQ
12negative regulation of gluconeogenesisGO:0457219.3ADIPOQ, INS
13energy reserve metabolic processGO:0061129.3LEP, INS
14positive regulation of cellular protein metabolic processGO:0322709.3ADIPOQ, INS
15circadian rhythmGO:0076239.3ADIPOQ, LEP
16positive regulation of insulin receptor signaling pathwayGO:0466289.2IRS1, LEP, INS
17regulation of insulin secretionGO:0507969.0LEP, INS
18positive regulation of peptidyl-tyrosine phosphorylationGO:0507319.0INS, ADIPOQ
19response to nutrientGO:0075849.0ADIPOQ, PPARG
20positive regulation of cell proliferationGO:0082849.0INS, LEP, IRS1
21cellular response to insulin stimulusGO:0328699.0PPARG, IRS1, ADIPOQ
22positive regulation of glucose importGO:0463268.9INS, IRS1, ADIPOQ
23glucose metabolic processGO:0060068.8ADIPOQ, LEP, INS
24glucose homeostasisGO:0425938.4ADIPOQ, IRS1, INS, PPARG

Molecular functions related to Lipoatrophic Diabetes according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1insulin receptor bindingGO:0051589.4IRS1, INS
2insulin-like growth factor receptor bindingGO:0051599.1IRS1, INS
3hormone activityGO:0051798.0RETN, ADIPOQ, LEP, INS

Products for genes affiliated with Lipoatrophic Diabetes

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Lipoatrophic Diabetes

About this section
4CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
29IUPHAR
30KEGG
35MeSH
36MESH via Orphanet
37MGI
40NCIt
41NDF-RT
44NINDS
45Novoseek
47OMIM
48OMIM via Orphanet
52PubMed
53QIAGEN
59SNOMED-CT via Orphanet
62UMLS
63UMLS via Orphanet